Experienced in Encopresis

Dr. Fred B. Rosenberg

Gastroenterology
Regional Gastroenterology Associates Of Lancaster, Ltd.
2112 Harrisburg Pike, Suite 202, 
Lancaster, PA 
Accepting New Patients
Experienced in Encopresis
Regional Gastroenterology Associates Of Lancaster, Ltd.
2112 Harrisburg Pike, Suite 202, 
Lancaster, PA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Fred Rosenberg is a Gastroenterologist in Lancaster, Pennsylvania. Dr. Rosenberg is rated as an Experienced provider by MediFind in the treatment of Encopresis. His top areas of expertise are Gastroesophageal Reflux Disease (GERD), Gastric Dysmotility, Diarrhea, Gastrectomy, and Endoscopy. Dr. Rosenberg is currently accepting new patients.

His clinical research consists of co-authoring 2 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Gastroenterology
Licenses
Internal Medicine in IL
Languages Spoken
English
Italian
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

REGIONAL GASTROENTEROLOGY ASSOCIATES OF LANCASTER, LTD.
2112 Harrisburg Pike, Suite 202, Lancaster, PA 17601

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 307)
Enrollment Status: Terminated
Publish Date: March 31, 2022
Intervention Type: Drug, Other
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Crohn's Disease (CARMEN CD 306)
Enrollment Status: Terminated
Publish Date: May 11, 2021
Intervention Type: Other, Biological
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)
Enrollment Status: Terminated
Publish Date: April 26, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

2 Total Publications

Challenges Facing Independent Integrated Gastroenterology 2017.
Challenges Facing Independent Integrated Gastroenterology 2017.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: February 19, 2017
Similar Doctors
Distinguished in Encopresis
Dr. Sarina Pasricha
Gastroenterology
Distinguished in Encopresis
Dr. Sarina Pasricha
Gastroenterology

Christiana Care Health Services Inc

4755 Ogletown Stanton Rd, 
Newark, DE 
 (44.8 miles away)
302-733-1000
Languages Spoken:
English
See accepted insurances

Sarina Pasricha is a Gastroenterologist in Newark, Delaware. Dr. Pasricha is rated as a Distinguished provider by MediFind in the treatment of Encopresis. Her top areas of expertise are Barrett Esophagus, Bowel Incontinence, Hemorrhoids, Endoscopy, and Gastrectomy.

Advanced in Encopresis
Dr. Deborah Bethards
Gastroenterology
Advanced in Encopresis
Dr. Deborah Bethards
Gastroenterology
1 Continental Dr, 
Elizabethtown, PA 
 (14.0 miles away)
800-243-1455
Languages Spoken:
English
See accepted insurances

Deborah Bethards is a Gastroenterologist in Elizabethtown, Pennsylvania. Dr. Bethards is rated as an Advanced provider by MediFind in the treatment of Encopresis. Her top areas of expertise are Gastric Dysmotility, Gastroparesis, Swallowing Difficulty, Encopresis, and Endoscopy.

Advanced in Encopresis
Dr. Anan Said
Gastroenterology
Advanced in Encopresis
Dr. Anan Said
Gastroenterology

Regional Gastroenterology Associates Of Lancaster, Ltd.

2112 Harrisburg Pike, Suite 202, 
Lancaster, PA 
 (0.1 miles away)
717-869-4600
Languages Spoken:
English
See accepted insurances

Anan Said is a Gastroenterologist in Lancaster, Pennsylvania. Dr. Said is rated as an Advanced provider by MediFind in the treatment of Encopresis. His top areas of expertise are Familial Adenomatous Polyposis, Trichohepatoenteric Syndrome, Diarrhea, Colonoscopy, and Gastrectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Rosenberg's expertise for a condition
ConditionClose
        View All 46 Experienced Conditions
        Want to save this doctor for later?
        Sign Up
        Is this your doctor?
        Find A Second Opinion
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile